LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

Search

Pfizer

Cerrado

SectorSanidad

25.17 0.28

Resumen

Variación precio

24h

Actual

Mínimo

25.13

Máximo

25.21

Métricas clave

By Trading Economics

Ingresos

-45M

2.9B

Ventas

938M

15B

P/B

Media del Sector

13.005

34.427

BPA

0.78

Rentabilidad por dividendo

6.92

Margen de beneficios

19.982

Empleados

81,000

EBITDA

266M

5.3B

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+13.72% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

6.92%

2.47%

Próximas Ganancias

28 oct 2025

Fecha Próximo Dividendo

2 sept 2025

Próxima Fecha de Ex Dividendo

7 nov 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

6B

140B

Apertura anterior

24.89

Cierre anterior

25.17

Noticias sobre sentimiento de mercado

By Acuity

52%

48%

294 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Pfizer Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

5 ago 2025, 11:34 UTC

Ganancias

Pfizer Boosts 2025 Adjusted EPS Outlook Following 2Q Gains

5 ago 2025, 20:44 UTC

Ganancias

These Stocks Moved the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More -- Barrons.com

5 ago 2025, 18:20 UTC

Ganancias

Pfizer Stock Rises as Earnings Smash Expectations. But These Challenges Remain. -- Barrons.com

5 ago 2025, 18:17 UTC

Ganancias

These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More -- Barrons.com

5 ago 2025, 16:04 UTC

Charlas de Mercado

Pfizer's New Tax Rate Helps Boost Adj EPS Outlook -- Market Talk

5 ago 2025, 15:25 UTC

Ganancias

Correction to These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, Caterpillar, BP, and More -- Barrons.com

5 ago 2025, 13:56 UTC

Ganancias

Pfizer Stock Rises as Earnings Smash Expectations. But These Challenges Remain. -- Barrons.com

5 ago 2025, 11:43 UTC

Ganancias

Pfizer Stock Pops as Earnings Smash Expectations. Guidance Hiked in Face of Tariffs. -- Barrons.com

5 ago 2025, 11:27 UTC

Ganancias

Update: These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More -- Barrons.com

5 ago 2025, 10:57 UTC

Ganancias

Pfizer Stock Pops as Earnings Smash Expectations. Why the Outlook Has Been Hiked. -- Barrons.com

5 ago 2025, 10:55 UTC

Ganancias

Update: These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More -- Barrons.com

5 ago 2025, 10:53 UTC

Ganancias

Pfizer Boosts 2025 Profit Estimate In A Sign Of 'Confidence' -- MarketWatch

5 ago 2025, 10:51 UTC

Ganancias

Pfizer: On Track to Deliver About $7.2B Overall Cost Savings From Cost-Improvement Initiatives b/ End of 2027 >PFE

5 ago 2025, 10:50 UTC

Ganancias

Pfizer: Expects to Continue to De-Lever in Prudent Manner to Maintain Balanced Capital-Allocation Strategy >PFE

5 ago 2025, 10:49 UTC

Ganancias

Pfizer: Current Financial Guidance Doesn't Anticipate Any Share Repurchases in 2025 >PFE

5 ago 2025, 10:49 UTC

Ganancias

Pfizer Now Sees 2025 Effective Tax Rate on Adjusted Income About 13%; Had Seen About 15% >PFE

5 ago 2025, 10:48 UTC

Ganancias

Pfizer Cuts Adjusted R&D Expenses View to $10.4-$11.4B From $10.7B-$11.7B >PFE

5 ago 2025, 10:48 UTC

Ganancias

Pfizer: Guidance Absorbs Impact of Potential Price Changes This Year Based on Letter Received July 31 From President Trump >PFE

5 ago 2025, 10:47 UTC

Ganancias

Pfizer: Guidance Absorbs Impact of Currently Imposed Tariffs From China, Canada, Mexico >PFE

5 ago 2025, 10:46 UTC

Ganancias

Pfizer Had Seen 2025 Adjusted EPS $2.80-$3.00 >PFE

5 ago 2025, 10:45 UTC

Ganancias

Pfizer Raises 2025 EPS Guidance >PFE

5 ago 2025, 10:45 UTC

Ganancias

Pfizer 2Q EPS 51c >PFE

5 ago 2025, 10:45 UTC

Ganancias

Pfizer Sees FY Adj EPS $2.90-Adj EPS $3.10 >PFE

5 ago 2025, 10:45 UTC

Ganancias

Pfizer 2Q Adj EPS 78c >PFE

5 ago 2025, 10:45 UTC

Ganancias

Pfizer 2Q Rev $14.7B >PFE

5 ago 2025, 10:45 UTC

Ganancias

Pfizer Sees FY Rev $61B-$64B >PFE

4 ago 2025, 15:26 UTC

Ganancias

Pfizer Reports Earnings Soon. The Stock Is Slumping for a Reason. -- Barrons.com

30 jul 2025, 18:36 UTC

Ganancias

UPS Stock Joins 7% Yielders in S&P 500. Here's Who Else Is in the Club. -- Barrons.com

9 jul 2025, 09:17 UTC

Acciones populares

Stocks to Watch Wednesday: Freeport-McMoRan, Glencore, Novo Nordisk -- WSJ

10 jun 2025, 12:18 UTC

Ganancias

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors. -- Barrons.com

Comparación entre iguales

Cambio de precio

Pfizer previsión

Precio Objetivo

By TipRanks

13.72% repunte

Estimación a 12 Meses

Media 28.59 USD  13.72%

Máximo 33 USD

Mínimo 24 USD

De acuerdo con 18 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Pfizer Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

18 ratings

6

Comprar

12

Mantener

0

Vender

Puntuación técnica

By Trading Central

22.855 / 23.85Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

294 / 374 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.